metaX Institut für Diätetik

metaX Institut für Diätetik is a specialized medical nutrition company based in Germany that focuses on developing and manufacturing dietary products for individuals with rare inborn errors of metabolism (IEM). The company provides a comprehensive portfolio of amino acid supplements and low-protein foods tailored for conditions such as Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), and organic acidurias. Founded with a mission to improve the quality of life for patients requiring strict dietary management, metaX offers both clinical-grade supplements and everyday food alternatives like bread and pasta. In 2018, the company was acquired by Cambrooke Therapeutics, a subsidiary of the Ajinomoto Group, to expand its global reach in the medical foods market. The company is recognized for its high-quality formulations and its commitment to supporting the metabolic community through education and specialized nutritional solutions.